Thank you, Ted. Good morning, everyone. Total investment income for the December quarter was approximately $78.4 million, a decline of $4.2 million, or 5.1% from the prior quarter. This reduction was largely driven by lower interest income resulting from decreased base rates, new non-accrual positions, and continued asset spread compression. Weighted average yield at cost of our directly originated lending portfolio averaged 10% for the December quarter, compared to 10.3% in the previous quarter. Prepayment income was approximately $2.4 million, down from $3.2 million last quarter. Fee income was approximately $1.0 million, up from about $0.5 million last quarter. Dividend income was $231,000, relatively flat quarter-over-quarter. Our net expenses for the quarter were $42.4 million, a decline of $4.9 million, or 10.4% from the prior quarter. This decline was driven primarily by the absence of incentive fees, reflecting the impact of the total return hurdle feature, which eliminated the incentive fee, as well as lower interest expense, partially offset by higher administrative services. Portfolio had a net loss of $45.3 million, or $0.49 per share. Negative contributors for the quarter included our investments in LendingPoint, Renovo, Amperity, Bird Rides, New Era, and Banner Solutions, among others. Positive contributors to performance for the quarter included our investment in Merx and Compass Health, among others. As discussed on last quarter's call, in October, we extended and repriced our revolving credit facility, and we upsized and repriced our first CLO. In connection with these financing activities, we recorded a realized loss of approximately $3.4 million, or $0.04 per share, in the December quarter. Cost of debt for the quarter declined to 5.95%, down from 6.37% in the prior quarter, largely driven by these refinancing activities as well as lower base rates. For the December quarter, net investment income per share was $0.39. GAAP net loss per share was $0.14, or $0.10 excluding the aforesaid impact related to the one-time financing costs. Turning to the balance sheet, at the end of December, the portfolio had a fair value of $3.17 billion. Total principal debt outstanding was $2.0 billion. Total net assets stood at $1.31 billion, or $14.18 per share. The company ended the quarter at 1.45x net leverage. Gross fundings for the quarter, excluding revolvers, totaled $156 million, and net fundings for the quarter were +$25 million. This concludes our prepared remarks. Operator, please open the call to questions.